These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 9422426)
21. Allograft survival following immunization with membrane-bound or soluble peptide MHC class I donor antigens: factors relevant for the induction of rejection by indirect recognition. Terness P; Dufter C; Otto G; Opelz G Transpl Int; 1996; 9(1):2-8. PubMed ID: 8748404 [TBL] [Abstract][Full Text] [Related]
22. A clinically feasible approach to induce delayed tolerance in recipients of prior kidney or vascularized composite allotransplants. Chen B; Xu H; Corbin DR; Ildstad ST Transplantation; 2012 Oct; 94(7):671-8. PubMed ID: 22948444 [TBL] [Abstract][Full Text] [Related]
23. Indirect recognition of donor HLA-DR peptides in organ allograft rejection. Liu Z; Colovai AI; Tugulea S; Reed EF; Fisher PE; Mancini D; Rose EA; Cortesini R; Michler RE; Suciu-Foca N J Clin Invest; 1996 Sep; 98(5):1150-7. PubMed ID: 8787678 [TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial cell apoptosis induced by anti-donor non-MHC antibodies: a possible injury pathway contributing to chronic allograft rejection. Wu GD; Jin YS; Salazar R; Dai WD; Barteneva N; Barr ML; Barsky LW; Starnes VA; Cramer DV J Heart Lung Transplant; 2002 Nov; 21(11):1174-87. PubMed ID: 12431491 [TBL] [Abstract][Full Text] [Related]
25. Indirect recognition of MHC class I allopeptides accelerates lung allograft rejection in miniature swine. Shoji T; Wain JC; Houser SL; Benjamin LC; Johnston DR; Hoerbelt R; Hasse RS; Lee RS; Muniappan A; Guenther DA; Bravard MA; Ledgerwood LG; Sachs DH; Sayegh MH; Madsen JC; Allan JS Am J Transplant; 2005 Jul; 5(7):1626-34. PubMed ID: 15943620 [TBL] [Abstract][Full Text] [Related]
26. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction. Vella JP; Spadafora-Ferreira M; Murphy B; Alexander SI; Harmon W; Carpenter CB; Sayegh MH Transplantation; 1997 Sep; 64(6):795-800. PubMed ID: 9326400 [TBL] [Abstract][Full Text] [Related]
27. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II. Pietra BA; Wiseman A; Bolwerk A; Rizeq M; Gill RG J Clin Invest; 2000 Oct; 106(8):1003-10. PubMed ID: 11032860 [TBL] [Abstract][Full Text] [Related]
29. Immunosuppressive effects of an HLA class I-derived peptide in a rat cardiac allograft model. Hanaway MJ; Geissler EK; Wang J; Fechner JH; Buelow R; Knechtle SJ Transplantation; 1996 Apr; 61(8):1222-8. PubMed ID: 8610422 [TBL] [Abstract][Full Text] [Related]
30. Patterns of allosensitization in allograft recipients: long-term cardiac allograft acceptance is associated with active alloantibody production in conjunction with active inhibition of alloreactive delayed-type hypersensitivity. VanBuskirk AM; Wakely ME; Sirak JH; Orosz CG Transplantation; 1998 Apr; 65(8):1115-23. PubMed ID: 9583874 [TBL] [Abstract][Full Text] [Related]
31. New strategies for early diagnosis of heart allograft rejection. Tugulea S; Ciubotariu R; Colovai AI; Liu Z; Itescu S; Schulman LL; Fisher PE; Hardy MA; Rose EA; Michler RE; Cortesini R; Suciu-Foca N Transplantation; 1997 Sep; 64(6):842-7. PubMed ID: 9326408 [TBL] [Abstract][Full Text] [Related]
32. T and B cell responsiveness to donor class I MHC molecules and peptides in long survivors with kidney allografts. Benham Am; Sawyer GJ; Fabre JW Transplantation; 1996 May; 61(10):1455-60. PubMed ID: 8633370 [TBL] [Abstract][Full Text] [Related]
33. CD28-B7 T-cell co-stimulatory blockade potentiates the effects of intrathymic immunomodulation in sensitized graft recipients. Stadlbauer TH; Schaub M; Korom S; Onodera K; Sayegh MH; Kupiec-Weglinski JW Transplantation; 1997 Dec; 64(12):1816-22. PubMed ID: 9422425 [TBL] [Abstract][Full Text] [Related]
34. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms. Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S Transplantation; 1999 Feb; 67(3):444-50. PubMed ID: 10030293 [TBL] [Abstract][Full Text] [Related]
35. Acquired systemic tolerance to rat cardiac allografts induced by intrathymic inoculation of synthetic polymorphic MHC class I allopeptides. Chowdhury NC; Murphy B; Sayegh MH; Jin MX; Roy DK; Hardy MA; Oluwole SF Transplantation; 1996 Dec; 62(12):1878-82. PubMed ID: 8990380 [TBL] [Abstract][Full Text] [Related]
36. Induction of allograft nonresponsiveness after intrathymic inoculation with donor class I allopeptides. I. Correlation of graft survival with antidonor IgG antibody subclasses. Mhoyan A; Cramer DV; Baquerizo A; Shirwan H Transplantation; 1997 Dec; 64(12):1665-70. PubMed ID: 9422399 [TBL] [Abstract][Full Text] [Related]
37. Renal allograft rejection, lymphocyte infiltration, and de novo donor-specific antibodies in a novel model of non-adherence to immunosuppressive therapy. Kühne L; Jung B; Poth H; Schuster A; Wurm S; Ruemmele P; Banas B; Bergler T BMC Immunol; 2017 Dec; 18(1):52. PubMed ID: 29258420 [TBL] [Abstract][Full Text] [Related]
38. Loss of tolerance to a maternal kidney transplant is selective for HLA class II: evidence from trans-vivo DTH and alloantibody analysis. Burlingham WJ; Jankowska-Gan E; VanBuskirk A; Orosz CG; Lee JH; Kusaka S Hum Immunol; 2000 Dec; 61(12):1395-402. PubMed ID: 11163098 [TBL] [Abstract][Full Text] [Related]
39. Peripheral donor leukocytes prolong survival of rat renal allografts. Noris M; Azzollini N; Mister M; Pezzotta A; Piccinini G; Casiraghi F; Cugini D; Perico N; Orisio S; Remuzzi G Kidney Int; 1999 Sep; 56(3):1101-12. PubMed ID: 10469380 [TBL] [Abstract][Full Text] [Related]